SCHEMBL6550871

SCHEMBL6550871

CCOC(OC(=O)O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
PTGS2 P35354 1/20 0.46
MMP8 P22894 1/20 0.42
POLB P06746 1/20 0.42
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
PIN1 Q13526 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6668227 0.84 TSHR (0.50) BCHEACHEPTGS2MMP8POLB
SCHEMBL27191 0.82 ACHE (0.47) BCHEACHEPTGS2POLBL3MBTL1
SCHEMBL2145840 0.82 BCHE (0.44) BCHEACHEPTGS2MMP8POLB
SCHEMBL11644264 0.82 ACHE (0.41) BCHEACHEPTGS2MMP8POLB
SCHEMBL21198904 0.81 CYP2D6 (0.38) L3MBTL1KMT2ATSHRLMNAALDH1A1
SCHEMBL5150651 0.80 ALDH1A1 (0.51) BCHEACHEPTGS2MMP8POLB
SCHEMBL286685 0.79 KMT2A (0.48) L3MBTL1KMT2ATSHRLMNAGAA
Bromide SCHEMBL30327209 0.78 ACHE (0.44) BCHEACHEPTGS2POLBL3MBTL1
SCHEMBL2435557 0.78 L3MBTL1 (0.42) BCHEACHEPTGS2MMP8POLB
SCHEMBL14763765 0.77 ACHE (0.45) BCHEACHEPTGS2MMP8POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024064769-A1 INDUCTION OF STEM-LIKE ACTIVATED T CELLS PHIO PHARMACEUTICALS CORP. (US) 2024-03-28 WO disclosed
EP-4284854-A1 REPROCESSABLE COMPOSITIONS Massachusetts Institute of Technology (US) 2023-12-06 EP disclosed
WO-2023168077-A1 PHENOL-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE CONAGEN INC. (US) 2023-09-07 WO disclosed
WO-2022164503-A1 REPROCESSABLE COMPOSITIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-08-04 WO disclosed
WO-2022133265-A1 STEROIDAL COMPOUND DERIVATIVES AS THERAPEUTIC AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORTED (US) 2022-06-23 WO disclosed
CN-101065452-B Process for making perylene pigment compositions SUN CHEMICAL CORP 2011-07-27 CN disclosed
CN-101065452-A Process for making perylene pigment compositions SUN CHEMICAL CORP (US) 2007-10-31 CN disclosed
EP-1483335-A1 PROCESS FOR MAKING PERYLENE PIGMENT COMPOSITIONS SUN CHEMICAL CORPORATION (US) 2004-12-08 EP disclosed
US-6692562-B2 IMIDATION OF PERYLENETETRACARBOXYLIC ACID DERIVATIVE; ALKYLATION SUN CHEMICAL CORPORATION 2004-02-17 US disclosed
WO-2003076519-A1 PROCESS FOR MAKING PERYLENE PIGMENT COMPOSITIONS SUN CHEMICAL CORPORATION (US) 2003-09-18 WO disclosed
US-20030167971-A1 Process for making perylene pigment compositions SUN CHEMICAL CORPORATION 2003-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030167971-A1 Process for making perylene pigment compositions ATXN2L, HACL2, TYR BCHE 3215/4885ACHE 3451/4885PTGS2 2976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.